Tae-Gyu Nam Selected Research

Tae-Gyu Nam Research Topics

Disease

7	Inflammation (Inflammations) 01/2021 - 10/2014
6	Colitis 01/2021 - 10/2016
6	Neoplasms (Cancer) 01/2020 - 01/2016
4	Body Weight (Weight, Body) 09/2021 - 10/2016
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 10/2016
4	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 02/2009
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 01/2017
3	Breast Neoplasms (Breast Cancer) 11/2016 - 01/2016
2	Non-alcoholic Fatty Liver Disease 09/2021 - 12/2018
2	Lung Neoplasms (Lung Cancer) 10/2018 - 10/2017
2	Multiple Sclerosis 01/2018 - 01/2018
2	Disease Progression 02/2017 - 01/2017
2	Malaria 11/2011 - 07/2008
1	Proteostasis Deficiencies 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Edema (Dropsy) 01/2021
1	Necrosis 12/2020
1	Melanoma (Melanoma, Malignant) 08/2020
1	Brain Infarction 01/2018
1	Ulcerative Colitis 01/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Triple Negative Breast Neoplasms 11/2016
1	Neoplasm Metastasis (Metastasis) 11/2016
1	Neuroinflammatory Diseases 01/2016
1	Optic Nerve Injuries 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 12/2009

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
4	Peroxidase (Myeloperoxidase)IBA 01/2021 - 10/2016
3	BJ-1108IBA 01/2021 - 01/2016
3	Dextran SulfateIBA 01/2021 - 01/2018
3	CytokinesIBA 01/2021 - 10/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 10/2017
3	Sunitinib (Sutent)FDA Link 10/2018 - 06/2016
3	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2016
2	LipidsIBA 09/2021 - 12/2018
2	AntioxidantsIBA 01/2021 - 12/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2016
2	2,4,5-trimethylpyridin-3-olIBA 12/2020 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 10/2016
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2018 - 10/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018 - 10/2017
2	AcidsIBA 08/2018 - 10/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2017
2	Serotonin (5 Hydroxytryptamine)IBA 11/2016 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 06/2016 - 01/2016
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 09/2021
1	4-methylcatecholIBA 09/2021
1	Rutin (Rutoside)IBA 09/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Claudin-1IBA 01/2021
1	Claudin-3IBA 01/2021
1	A-factor (Streptomyces)IBA 01/2021
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	alkoxyl radicalIBA 12/2020
1	Therapeutic UsesIBA 10/2020
1	tofacitinibIBA 10/2020
1	compound 17IBA 10/2020
1	Melanins (Melanin)IBA 08/2020
1	Monophenol Monooxygenase (Tyrosinase)IBA 08/2020
1	PlatinumIBA 01/2020
1	Oleic Acid (Oleate)IBA 12/2018
1	AMP-Activated Protein KinasesIBA 12/2018
1	Cilostazol (Pletal)FDA LinkGeneric 12/2018
1	azacyclonolIBA 10/2018
1	pyridineIBA 10/2018
1	VitaminsIBA 10/2018
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	AUY 954IBA 01/2018
1	BJ-1301IBA 10/2017
1	alpha-Tocopherol FDA Link 10/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2017
1	Stem Cell FactorIBA 10/2017
1	LigandsIBA 10/2017
1	InterferonsIBA 01/2017
1	BJ-3105IBA 01/2017
1	Hormones (Hormone)IBA 11/2016
1	serotonin 7 receptorIBA 11/2016
1	Tryptophan HydroxylaseIBA 11/2016
1	matrigelIBA 11/2016
1	Cyclin DIBA 06/2016
1	Phosphotransferases (Kinase)IBA 06/2016
1	Transcription Factors (Transcription Factor)IBA 06/2016
1	tyrosine receptor (receptor, tyrosine)IBA 06/2016
1	5-hydroxy-7-azaindolin-2-oneIBA 06/2016
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 06/2016
1	SurvivinIBA 06/2016
1	GAP-43 Protein (GAP 43 Protein)IBA 01/2016
1	PolyphenolsIBA 10/2014
1	DecoquinateIBA 11/2011
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2009
1	Integrin alpha4IBA 02/2009
1	Biological ProductsIBA 07/2008
1	Antiparasitic Agents (Antiparasitics)IBA 07/2008

Therapy/Procedure

4	Therapeutics 01/2021 - 02/2009
3	Oral Administration 01/2021 - 01/2018
1	Drug Therapy (Chemotherapy) 11/2016